Janux Therapeutics, Inc. (JANX)
15.74
-0.84
(-5.07%)
USD |
NASDAQ |
Dec 09, 16:00
15.74
0.00 (0.00%)
After-Hours: 06:24
Janux Therapeutics EPS Diluted (Quarterly): -0.392 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Stoke Therapeutics, Inc. | -0.6543 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Editas Medicine, Inc. | -0.2788 |
| Syndax Pharmaceuticals, Inc. | -0.7009 |
| Entrada Therapeutics, Inc. | -1.064 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.31M |
| Revenue (Quarterly) | 10.00M |
| Total Expenses (Quarterly) | 34.31M |
| Enterprise Value | -19.61M |
| Gross Profit Margin (Quarterly) | 94.99% |
| Profit Margin (Quarterly) | -243.1% |
| Earnings Yield | -10.64% |
| Normalized Earnings Yield | -10.64 |